Featuring perspectives from Dr John M Pagel and Ms Lesley Camille Ballance, including the following topics:

• Introduction (0:00)
• The recent history of CLL treatment (2:09)
• Bruton tyrosine kinase (BTK) inhibitors (19:35)
• Case: A woman in her early 50s with previously untreated CLL who receives acalabrutinib — Lesley Camille Ballance, MSN, FNP-BC (23:31)
• Key data sets on BTK inhibitors in CLL (38:04)
• Case: A woman in her mid-40s with CLL who was initially observed off treatment — Ms Ballance (41:55)
• Case: A man in his early 60s with favorable-risk, IGHV-mutated CLL — 13q deletion — Ms Ballance (47:49)
• Case: A woman in her early 70s with multiregimen-relapsed CLL — Ms Balance (51:55)
• Key data sets on emerging therapies for CLL (54:01)

CME information and select publications